NCT05390424招募中不适用
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
University Hospital, Rouen11 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年12月2日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 500
- 试验地点
- 11
- 主要终点
- Number of person with an active hepatitis B infection
研究概览
简要总结
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Former or active intravenous and/or nasal drug user
- •Person on opiate substitution therapy
排除标准
- •Person with known active viral infection(s)
研究组 & 干预措施
Drug user
Experimental
Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection
干预措施: Blood collection using Dried Blood Spot (Diagnostic Test)
结局指标
主要结局
Number of person with an active hepatitis B infection
时间窗: Day 1
Number of person with an active AIDS infection
时间窗: Day 1
Number of person with an active hepatitis C infection
时间窗: Day 1
次要结局
未报告次要终点
研究者
研究点 (11)
Loading locations...
相似试验
已完成
不适用
Screening for HIV, hepatitis B, Hepatitis C, syphilis and creatinine on self-collected dried blood spot samples*NL-OMON49756GGD Amsterdam200
已完成
不适用
Evaluation of screening for hepatitis B and C virus infection as part of the general health examination in primary care practices (GesuHep)B15-B19Viral hepatitisDRKS00031077Medizinische Hochschule Hannover337
已完成
不适用
Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingHuman Immunodeficiency Virus InfectionHepatitis CNCT01447680G & W Laboratories Inc.1,600
已完成
不适用
A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological AssaysImmunologic TestsNCT01098006GlaxoSmithKline99
已完成
不适用
Access HBV Assays - European Union (EU) Clinical Trial Protocol -HBVNCT04904835Beckman Coulter, Inc.21,210